Background: Elevated
liver enzymes are markers of liver steatosis and metabolic syndrome. There is a
strong relation between the increase of aminotransferase levels and with
cardiovascular complications, independent of all aspects of metabolic syndrome.
The aim of this study was to examine the effect of virgin olive oil on ALT and
AST and anthropometric parameters in
the NAFLD patients with weight loss diet.
Methods: This clinical
trial was carried out on 50 patients with non-alcoholic fatty liver (mean age of
45.91 ±9.61 years, mean BMI 29.7 ± 0.58 Kg/m2). Subjects were randomly assigned into A
group (receiving the equivalent of 20% of total daily energy requirement from
olive oil) or B (receiving their normal consumption of oil) for 12 weeks. All the patients received a hypocaloric
diet during the study. At the beginning and end of the study, dietary
assessment, anthropometric parameters and serum levels of ALT and AST were
measured.
Results: At the end of the study a significant
decrease in BMI, weight and waist circumstances were observed in both the
groups. But there was no significant statistical difference between the two
groups. There was a significant difference in ALT and AST in A group as
compared to B group.
Conclusions: The consumption
of diet enriched with olive oil along with slight weight reduction reinforces
desired effects of weight lost in decreasing the hepatic enzymes.
Rights and permissions | |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |